CDC’s Doxycycline Prophylaxis Guidelines Raise Concerns Over STI Prevention Inclusivity

The CDC’s new guidelines on doxycycline post-exposure prophylaxis (doxy PEP) aim to combat rising STIs in the U.S., but significant gaps remain in accessibility for cisgender women and transgender men. This exclusion raises concerns about inclusivity in STI prevention research, emphasizing the need for equitable access to effective health measures for all demographics. As the STI epidemic escalates, comprehensive strategies are crucial to protect sexual health across diverse populations.